April 12, 2024
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
April 5, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is researching how different rates of cerebral small vessel disease and genetic differences contribute to higher rates of Alzheimer's disease and related dementias in non-Hispanic Black populations compared to non-Hispanic white patients.
July 13, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is leading two research projects to learn more about the relationship between sickle cell disease, stroke and cognitive impairment.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.